Global Next Generation Implants (NGI) Market Research Report 2023

Publication ID:

PB503239316

Publication Date:

March 23, 2023

Pages:

100

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Internet [2]

Computing & Electronics [3]

Description:

Highlights
The global Next Generation Implants (NGI) market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Next Generation Implants (NGI) is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Next Generation Implants (NGI) is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Next Generation Implants (NGI) in Orthopedic Implants is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Next Generation Implants (NGI) include Abbott Laboratories, Arthrex, Biotronik SE & Co. KG, BOSTON SCIENTIFIC CORPORATION, C. R. BARD, INC., DANAHER CORPORATION, DENTSPLY SIRNA Inc., Edwards Lifesciences Corporation and Globus Medical Inc., etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Next Generation Implants (NGI), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Next Generation Implants (NGI).
The Next Generation Implants (NGI) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Next Generation Implants (NGI) market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Next Generation Implants (NGI) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Abbott Laboratories
Arthrex
Biotronik SE & Co. KG
BOSTON SCIENTIFIC CORPORATION
C. R. BARD, INC.
DANAHER CORPORATION
DENTSPLY SIRNA Inc.
Edwards Lifesciences Corporation
Globus Medical Inc.
Integer Holdings Corporation
Integra LifeSciences Corporation
Institut Straumann AG
LifeNet Health, Inc.
LivaNova PLC
Novartis International AG
Segment by Type
Metals & Metal Alloys
Ceramics
Polymers
Biologics
Others
Segment by Application
Orthopedic Implants
Cardiovascular Implants
Ocular Implants
Dental Implants
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Next Generation Implants (NGI) companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Next Generation Implants (NGI) Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Metals & Metal Alloys
1.2.3 Ceramics
1.2.4 Polymers
1.2.5 Biologics
1.2.6 Others
1.3 Market by Application
1.3.1 Global Next Generation Implants (NGI) Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Orthopedic Implants
1.3.3 Cardiovascular Implants
1.3.4 Ocular Implants
1.3.5 Dental Implants
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Next Generation Implants (NGI) Market Perspective (2018-2029)
2.2 Next Generation Implants (NGI) Growth Trends by Region
2.2.1 Global Next Generation Implants (NGI) Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Next Generation Implants (NGI) Historic Market Size by Region (2018-2023)
2.2.3 Next Generation Implants (NGI) Forecasted Market Size by Region (2024-2029)
2.3 Next Generation Implants (NGI) Market Dynamics
2.3.1 Next Generation Implants (NGI) Industry Trends
2.3.2 Next Generation Implants (NGI) Market Drivers
2.3.3 Next Generation Implants (NGI) Market Challenges
2.3.4 Next Generation Implants (NGI) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Next Generation Implants (NGI) Players by Revenue
3.1.1 Global Top Next Generation Implants (NGI) Players by Revenue (2018-2023)
3.1.2 Global Next Generation Implants (NGI) Revenue Market Share by Players (2018-2023)
3.2 Global Next Generation Implants (NGI) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Next Generation Implants (NGI) Revenue
3.4 Global Next Generation Implants (NGI) Market Concentration Ratio
3.4.1 Global Next Generation Implants (NGI) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Next Generation Implants (NGI) Revenue in 2022
3.5 Next Generation Implants (NGI) Key Players Head office and Area Served
3.6 Key Players Next Generation Implants (NGI) Product Solution and Service
3.7 Date of Enter into Next Generation Implants (NGI) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Next Generation Implants (NGI) Breakdown Data by Type
4.1 Global Next Generation Implants (NGI) Historic Market Size by Type (2018-2023)
4.2 Global Next Generation Implants (NGI) Forecasted Market Size by Type (2024-2029)
5 Next Generation Implants (NGI) Breakdown Data by Application
5.1 Global Next Generation Implants (NGI) Historic Market Size by Application (2018-2023)
5.2 Global Next Generation Implants (NGI) Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Next Generation Implants (NGI) Market Size (2018-2029)
6.2 North America Next Generation Implants (NGI) Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Next Generation Implants (NGI) Market Size by Country (2018-2023)
6.4 North America Next Generation Implants (NGI) Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Next Generation Implants (NGI) Market Size (2018-2029)
7.2 Europe Next Generation Implants (NGI) Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Next Generation Implants (NGI) Market Size by Country (2018-2023)
7.4 Europe Next Generation Implants (NGI) Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Next Generation Implants (NGI) Market Size (2018-2029)
8.2 Asia-Pacific Next Generation Implants (NGI) Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Next Generation Implants (NGI) Market Size by Region (2018-2023)
8.4 Asia-Pacific Next Generation Implants (NGI) Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Next Generation Implants (NGI) Market Size (2018-2029)
9.2 Latin America Next Generation Implants (NGI) Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Next Generation Implants (NGI) Market Size by Country (2018-2023)
9.4 Latin America Next Generation Implants (NGI) Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Next Generation Implants (NGI) Market Size (2018-2029)
10.2 Middle East & Africa Next Generation Implants (NGI) Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Next Generation Implants (NGI) Market Size by Country (2018-2023)
10.4 Middle East & Africa Next Generation Implants (NGI) Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Next Generation Implants (NGI) Introduction
11.1.4 Abbott Laboratories Revenue in Next Generation Implants (NGI) Business (2018-2023)
11.1.5 Abbott Laboratories Recent Development
11.2 Arthrex
11.2.1 Arthrex Company Detail
11.2.2 Arthrex Business Overview
11.2.3 Arthrex Next Generation Implants (NGI) Introduction
11.2.4 Arthrex Revenue in Next Generation Implants (NGI) Business (2018-2023)
11.2.5 Arthrex Recent Development
11.3 Biotronik SE & Co. KG
11.3.1 Biotronik SE & Co. KG Company Detail
11.3.2 Biotronik SE & Co. KG Business Overview
11.3.3 Biotronik SE & Co. KG Next Generation Implants (NGI) Introduction
11.3.4 Biotronik SE & Co. KG Revenue in Next Generation Implants (NGI) Business (2018-2023)
11.3.5 Biotronik SE & Co. KG Recent Development
11.4 BOSTON SCIENTIFIC CORPORATION
11.4.1 BOSTON SCIENTIFIC CORPORATION Company Detail
11.4.2 BOSTON SCIENTIFIC CORPORATION Business Overview
11.4.3 BOSTON SCIENTIFIC CORPORATION Next Generation Implants (NGI) Introduction
11.4.4 BOSTON SCIENTIFIC CORPORATION Revenue in Next Generation Implants (NGI) Business (2018-2023)
11.4.5 BOSTON SCIENTIFIC CORPORATION Recent Development
11.5 C. R. BARD, INC.
11.5.1 C. R. BARD, INC. Company Detail
11.5.2 C. R. BARD, INC. Business Overview
11.5.3 C. R. BARD, INC. Next Generation Implants (NGI) Introduction
11.5.4 C. R. BARD, INC. Revenue in Next Generation Implants (NGI) Business (2018-2023)
11.5.5 C. R. BARD, INC. Recent Development
11.6 DANAHER CORPORATION
11.6.1 DANAHER CORPORATION Company Detail
11.6.2 DANAHER CORPORATION Business Overview
11.6.3 DANAHER CORPORATION Next Generation Implants (NGI) Introduction
11.6.4 DANAHER CORPORATION Revenue in Next Generation Implants (NGI) Business (2018-2023)
11.6.5 DANAHER CORPORATION Recent Development
11.7 DENTSPLY SIRNA Inc.
11.7.1 DENTSPLY SIRNA Inc. Company Detail
11.7.2 DENTSPLY SIRNA Inc. Business Overview
11.7.3 DENTSPLY SIRNA Inc. Next Generation Implants (NGI) Introduction
11.7.4 DENTSPLY SIRNA Inc. Revenue in Next Generation Implants (NGI) Business (2018-2023)
11.7.5 DENTSPLY SIRNA Inc. Recent Development
11.8 Edwards Lifesciences Corporation
11.8.1 Edwards Lifesciences Corporation Company Detail
11.8.2 Edwards Lifesciences Corporation Business Overview
11.8.3 Edwards Lifesciences Corporation Next Generation Implants (NGI) Introduction
11.8.4 Edwards Lifesciences Corporation Revenue in Next Generation Implants (NGI) Business (2018-2023)
11.8.5 Edwards Lifesciences Corporation Recent Development
11.9 Globus Medical Inc.
11.9.1 Globus Medical Inc. Company Detail
11.9.2 Globus Medical Inc. Business Overview
11.9.3 Globus Medical Inc. Next Generation Implants (NGI) Introduction
11.9.4 Globus Medical Inc. Revenue in Next Generation Implants (NGI) Business (2018-2023)
11.9.5 Globus Medical Inc. Recent Development
11.10 Integer Holdings Corporation
11.10.1 Integer Holdings Corporation Company Detail
11.10.2 Integer Holdings Corporation Business Overview
11.10.3 Integer Holdings Corporation Next Generation Implants (NGI) Introduction
11.10.4 Integer Holdings Corporation Revenue in Next Generation Implants (NGI) Business (2018-2023)
11.10.5 Integer Holdings Corporation Recent Development
11.11 Integra LifeSciences Corporation
11.11.1 Integra LifeSciences Corporation Company Detail
11.11.2 Integra LifeSciences Corporation Business Overview
11.11.3 Integra LifeSciences Corporation Next Generation Implants (NGI) Introduction
11.11.4 Integra LifeSciences Corporation Revenue in Next Generation Implants (NGI) Business (2018-2023)
11.11.5 Integra LifeSciences Corporation Recent Development
11.12 Institut Straumann AG
11.12.1 Institut Straumann AG Company Detail
11.12.2 Institut Straumann AG Business Overview
11.12.3 Institut Straumann AG Next Generation Implants (NGI) Introduction
11.12.4 Institut Straumann AG Revenue in Next Generation Implants (NGI) Business (2018-2023)
11.12.5 Institut Straumann AG Recent Development
11.13 LifeNet Health, Inc.
11.13.1 LifeNet Health, Inc. Company Detail
11.13.2 LifeNet Health, Inc. Business Overview
11.13.3 LifeNet Health, Inc. Next Generation Implants (NGI) Introduction
11.13.4 LifeNet Health, Inc. Revenue in Next Generation Implants (NGI) Business (2018-2023)
11.13.5 LifeNet Health, Inc. Recent Development
11.14 LivaNova PLC
11.14.1 LivaNova PLC Company Detail
11.14.2 LivaNova PLC Business Overview
11.14.3 LivaNova PLC Next Generation Implants (NGI) Introduction
11.14.4 LivaNova PLC Revenue in Next Generation Implants (NGI) Business (2018-2023)
11.14.5 LivaNova PLC Recent Development
11.15 Novartis International AG
11.15.1 Novartis International AG Company Detail
11.15.2 Novartis International AG Business Overview
11.15.3 Novartis International AG Next Generation Implants (NGI) Introduction
11.15.4 Novartis International AG Revenue in Next Generation Implants (NGI) Business (2018-2023)
11.15.5 Novartis International AG Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Abbott Laboratories
Arthrex
Biotronik SE & Co. KG
BOSTON SCIENTIFIC CORPORATION
C. R. BARD, INC.
DANAHER CORPORATION
DENTSPLY SIRNA Inc.
Edwards Lifesciences Corporation
Globus Medical Inc.
Integer Holdings Corporation
Integra LifeSciences Corporation
Institut Straumann AG
LifeNet Health, Inc.
LivaNova PLC
Novartis International AG

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂